-
1
-
2
-
3
Corrigendum to ‘Interferon α: A potentially effective treatment for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation’ [Biology of Blood and Marrow Transplantation 21/11 (2015) 1939-1947]
Veröffentlicht in Biology of blood and marrow transplantation
VolltextArtikel -
4
-
5
Corrigendum to ‘Comparative Study of Tacrolimus and Short-Term Methotrexate: 2-Day versus 3-Day Methotrexate as Graft-versus-Host-Disease Prophylaxis after Umbilical Cord Blood Transplantation in Adults’ [Biology of Blood and Marrow Transplantation 26/2 (2020) 367-372]
Veröffentlicht in Biology of blood and marrow transplantation
VolltextArtikel -
6
-
7
Corrigendum to ‘Prophylactic donor lymphocyte infusion (DLI) followed by minimal residual disease and graft-versus host disease guided multiple DLIs could improve outcomes after allogeneic hematopoietic stem cell transplantation in patients with refractory/relapsed Acute Leukemia’ [Biology of Blood and Marrow Transplantation 23/8 (2017) 1311-1319]
Veröffentlicht in Biology of blood and marrow transplantation
VolltextArtikel -
8
Corrigendum to ‘Interferon-α is effective for treatment of minimal residual disease in patients with acute leukemia after allogeneic hematopoietic stem cell transplantation: results of a registry study’ [Biology of Blood and Marrow Transplantation 23/8 (2017) 1303-1310]
Veröffentlicht in Biology of blood and marrow transplantation
VolltextArtikel -
9
The 2009 Biology of Blood and Marrow Transplantation
Veröffentlicht in Biology of blood and marrow transplantation
VolltextArtikel -
10
Biology of Blood and Marrow Transplantation
Veröffentlicht in Biology of blood and marrow transplantation
VolltextArtikel -
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
Mucositis during Allogeneic Transplantation Determines Post-Transplant Serum Cyclosporin Levels
Veröffentlicht in Blood
VolltextArtikel -
19
-
20